Literature DB >> 34989961

Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma.

Yuan Li1,2, Xinxin Wang2, Shiyong Chen2, Biao Wu2, Yu He2, Xueqin Du2, Xiaojun Yang3,4,5,6.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system, with a high degree of malignancy. Although treatment methods are constantly improving, the mortality of patients is still very high, and the small nucleolar RNA host gene (SNHG) plays an important role in the occurrence and development of cancer. It can activate downstream signaling molecules by acting on microRNA and microRNA target genes, promote the proliferation, invasion, and migration of HCC cells, and provide a new molecular target for the treatment of HCC. At present, the molecular mechanisms of HCC remain unclear. In this study, the mechanism and signaling pathway of SNHG in HCC are reviewed, which provides a theoretical basis for the clinical treatment of HCC.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  HCC; LncRNA; SNHGs; Signaling pathway

Mesh:

Substances:

Year:  2022        PMID: 34989961     DOI: 10.1007/s11033-021-07018-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  63 in total

1.  Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes.

Authors:  C M Smith; J A Steitz
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 2.  Function and synthesis of small nucleolar RNAs.

Authors:  D Tollervey; T Kiss
Journal:  Curr Opin Cell Biol       Date:  1997-06       Impact factor: 8.382

Review 3.  HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer.

Authors:  Qing Tang; Swei Sunny Hann
Journal:  Cell Physiol Biochem       Date:  2018-05-24

4.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

Authors:  J Bruix; J M Llovet; A Castells; X Montañá; C Brú; M C Ayuso; R Vilana; J Rodés
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

Review 5.  Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.

Authors:  Jin-Lan Huang; Lei Zheng; Yan-Wei Hu; Qian Wang
Journal:  Carcinogenesis       Date:  2013-12-02       Impact factor: 4.944

Review 6.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

7.  Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.

Authors:  Quan Li; Long Liu; Weiming Li
Journal:  Tumour Biol       Date:  2014-07-23

8.  A mammalian gene with introns instead of exons generating stable RNA products.

Authors:  K T Tycowski; M D Shu; J A Steitz
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

9.  Syndrome of inappropriate anti-diuretic hormone secondary to non-cirrhotic primary hepatocellular carcinoma.

Authors:  Sherif Eltawansy; Johnson Gomez; Kenneth Liss; Noel Nivera; Mark Babyatsky
Journal:  Am J Case Rep       Date:  2015-01-23

Review 10.  Role of long non-coding RNA in drug resistance in non-small cell lung cancer.

Authors:  Leirong Wang; Leina Ma; Fei Xu; Wenxin Zhai; Shenghua Dong; Ling Yin; Jia Liu; Zhuang Yu
Journal:  Thorac Cancer       Date:  2018-05-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.